ARTICLE | Company News
Biosite's negative panel
March 24, 2000 8:00 AM UTC
The FDA's Clinical Chemistry and Clinical Toxicology Device Panel voted 6-3 against recommending approval of BSTE's Triage, a quantitative diagnostic that measures B-type natriuretic peptide (BNP), a ...